My PD Journey Summit 2016 to launch new composite scale measuring symptoms

News

Author: Parkinson's Life editorsPublished: 9 February 2016

Prep: Cook: Serves:

My PD Journey Summit 2016 will happen at the European Parliament on 18 February from 12:00-15:00. It will mark the exclusive launch of My PD Journey’s second major initiative – a new composite scale measuring motor-neuron and non-motor-neuron symptoms – and will showcase good practice examples taken by My PD Journey coalitions.

The summit will also feature personal accounts of Parkinson’s from patient and carer perspectives, as well as a policy response from the European Commission about what can be done at an EU and national level to address the challenges facing Parkinson’s patients, their families, and European healthcare systems at large.

Led by the EPDA, My PD Journey is a ground-breaking multi-stakeholder project for people with Parkinson’s in Europe. It aims to create an environment that ensures PwPs receive optimal and timely access to appropriate diagnosis, treatment and care.

For all registrations and all other information, please email sectretariat@mpdj.eu.

Last Month

Next Month

Go Back

Share this story

Comments

Resources & Tools

6 free guides to help raise awareness of Parkinson’s disease

Parkinson’s toolkits: practical guides for patient organisations

Tom Isaacs: a celebration

Hundreds gather to celebration of life of Parkinson’s campaigner

Oven-baked fish in butter and mixed herbs

This fish dish is light and healthy, perfect with rice or potatoes

Can awakening dormant neurons reverse Parkinson’s motor symptoms?

Reawakening dormant neurons could help reverse Parkinson’s motor symptoms, researchers in South Korea have found. While Parkinson’s is typically believed to be caused by neuronal death, a new study – published in ‘Current Biology’ journal – suggests that dormant neurons could be another cause. After completing an animal test – which treated the subjects with two compounds that block dopamine-producing neurons from becoming dormant – the researchers found these neurons to be “awakened”, allowing them to resume dopamine production. The researchers hope that this will lead to a disease-modifying treatment, especially for people in the early stages of Parkinson’s. Hoon Ryu, a senior author of the study and researcher at KIST Brain Science Institute, South Korea, said: “This research refutes the common belief that there is no disease-modifying treatment for Parkinson’s due to its basis on neuronal cell death.”

Parkinson’s could be present from birth, study finds

Parkinson’s may be present from birth in younger people with the condition, new research has found. The study – conducted by Cedars-Sinai Medical Centre, US, and published in ‘Nature Medicine’ journal – used induced stem cells from people with young-onset Parkinson’s, to grow dopamine-producing neurons and observe them for early warning signs of the condition. An abnormal pile-up of protein was found during the neurons’ development, including alpha-synuclein; which occurs in Parkinson’s. The scientists conjecture that Parkinson’s symptoms appear when the pile-up continues over 20 or 30 years. The team also found that the drug PEP005 – currently used against skin precancers – could help treat the condition. Michele Tagliati, vice chair and professor at Cedars-Sinai’s Department of Neurology and the study’s co-author, said: “This exciting new research provides hope that one day we may be able to detect and take early action to prevent this disease in at-risk individuals.”…

Testing saliva can help diagnose Parkinson’s, study finds

A saliva test carried out by doctors may be able to both diagnose Parkinson’s and detect the severity of the condition, according to a recent study published in medical journal ‘Neurological Sciences’. Several indicators of the development of Parkinson’s, including problems in the production of energy, can be easily detected in saliva. As part of the study, carried out by a team from the All India Institute of Medical Sciences, New Delhi, India, saliva samples were collected from 76 patients living with Parkinson’s, and 37 participants with good general health. They found that the saliva of those with Parkinson’s reflected evidence of alteration in neurotransmitters – chemical messengers that allow nerve cells to communicate. The researchers said the test “may highlight the characteristic changes in metabolite levels during the onset of Parkinson’s”.

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Phone
This field is for validation purposes and should be left unchanged.

My PD Journey Summit 2016 to launch new composite scale measuring symptoms

News

Author: Parkinson's Life editorsPublished: 9 February 2016

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Resources & Tools

6 free guides to help raise awareness of Parkinson’s disease

Perspectives

Tom Isaacs: a celebration

Recipes & Nutrition

Oven-baked fish in butter and mixed herbs

Can awakening dormant neurons reverse Parkinson’s motor symptoms?

Parkinson’s could be present from birth, study finds

Testing saliva can help diagnose Parkinson’s, study finds

{title}

Subscribe

My PD Journey Summit 2016 to launch new composite scale measuring symptoms

News

Author: Parkinson's Life editorsPublished: 9 February 2016

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Resources & Tools

6 free guides to help raise awareness of Parkinson’s disease

Perspectives

Tom Isaacs: a celebration

Recipes & Nutrition

Oven-baked fish in butter and mixed herbs

Can awakening dormant neurons reverse Parkinson’s motor symptoms?

Parkinson’s could be present from birth, study finds

Testing saliva can help diagnose Parkinson’s, study finds

{title}

Subscribe

Sign in